Ernandez Thomas, Mayadas Tanya Norton
Service of Nephrology, Department of Medical Specialties, University Hospital of Geneva, Geneva, Switzerland.
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Trends Mol Med. 2016 Feb;22(2):151-163. doi: 10.1016/j.molmed.2015.12.002. Epub 2016 Jan 7.
Kidney inflammation is a major contributor to progressive renal injury, leading to glomerulonephritis (GN) and chronic kidney disease. We review recent advances in our understanding of leukocyte accumulation in the kidney, emphasizing key chemokines involved in GN. We discuss features of renal inflammation such as the evolving concept of immune cell plasticity. We also describe certain aspects of organ-specific tissue microenvironments in shaping immune cell responses, as well as the current knowledge of how regulatory T lymphocytes impact on other immune effector cell populations to control inflammation. It is clear that present and future research in these areas may contribute to the development of novel targeted therapeutics, with the hope of alleviating the burden of end-stage renal disease (ESRD).
肾脏炎症是导致进行性肾损伤的主要因素,可引发肾小球肾炎(GN)和慢性肾脏病。我们综述了近期在理解白细胞在肾脏中积聚方面取得的进展,重点关注了参与GN的关键趋化因子。我们讨论了肾脏炎症的特征,如免疫细胞可塑性这一不断演变的概念。我们还描述了器官特异性组织微环境在塑造免疫细胞反应方面的某些方面,以及调节性T淋巴细胞如何影响其他免疫效应细胞群体以控制炎症的现有知识。很明显,这些领域目前和未来的研究可能有助于开发新型靶向治疗方法,有望减轻终末期肾病(ESRD)的负担。